TQH2929 injection

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Conditions

Generalized Pustular PsoriasisPsoriasis

Phase 1

A Clinical Study of TQH2929 in Healthy Adult Subjects

CompletedNCT06156280

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Psoriasis

Start: 2023-11-21End: 2025-03-21Updated: 2025-03-25

A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)

Active, not recruitingNCT06433531

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Generalized Pustular Psoriasis

Start: 2024-06-19End: 2025-12-31Updated: 2025-07-30